Vlad Coric

2017 - Biohaven Pharmaceutical Holding Co Ltd.

In 2017, Vlad Coric earned a total compensation of $3.9M as Chief Executive Officer at Biohaven Pharmaceutical Holding Co Ltd., a 392% increase compared to previous year.

Compensation breakdown

Bonus$337,500
Option Awards$3,086,473
Salary$420,892
Other$10,800
Total$3,855,665

Coric received $3.1M in option awards, accounting for 80% of the total pay in 2017.

Coric also received $337.5K in bonus, $420.9K in salary and $10.8K in other compensation.

Rankings

In 2017, Vlad Coric's compensation ranked 2,678th out of 14,666 executives tracked by ExecPay. In other words, Coric earned more than 81.7% of executives.

ClassificationRankingPercentile
All
2,678
out of 14,666
82nd
Division
Manufacturing
928
out of 5,772
84th
Major group
Chemicals And Allied Products
246
out of 2,075
88th
Industry group
Drugs
188
out of 1,731
89th
Industry
Pharmaceutical Preparations
151
out of 1,333
89th
Source: SEC filing on March 29, 2018.

Coric's colleagues

We found two more compensation records of executives who worked with Vlad Coric at Biohaven Pharmaceutical Holding Co Ltd. in 2017.

2017

James Engelhart

Biohaven Pharmaceutical Holding Co Ltd.

Chief Financial Officer

2017

Charles Conway

Biohaven Pharmaceutical Holding Co Ltd.

Chief Scientific Officer

News

In-depth

You may also like